# Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis

> **NCT00195819** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 82 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **BIOLOGICAL:** adalimumab (D2E7)
- **BIOLOGICAL:** placebo

## Key facts

- **NCT ID:** NCT00195819
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2004-10
- **Final completion:** 2009-06
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2011-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195819, "Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00195819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*